Is TissuGlu Surgical Adhesive right for your practice? Use our contact form to learn more.Contact Now
TissuGlu® Surgical Adhesive
Cohera Medical received CE Mark approval for TissuGlu® Surgical Adhesive in 2011. Since that time the company has developed substantial clinical experience in Europe and successfully established wide acceptance of TissuGlu. After thousands of cases, frequent presentations at medical specialty meetings, and 10+ clinical studies and user trials, the value and benefit of the technology has been firmly established.
TissuGlu Surgical Adhesive has been used in a broad range of surgical procedures that demonstrate the wide clinical versatility of the technology.
The recently completed U.S. TissuGlu® Surgical Adhesive No Drain Abdominoplasty Clinical Trial has shown that the use of TissuGlu to close dead space and approximate tissue planes may help to facilitate early healing and potentially eliminate the need for surgical drains.
Read more about No-drain Abdominoplasty with TissuGlu…
Inguinal Lymph Node Dissection (ILND)
TissuGlu Surgical Adhesive is being used to help reduce postoperative complications in patients undergoing inguinal lymph node dissection (ILND) for the treatment of malignant melanoma.
Read more about Inguinal Lymph Node Dissection with TissuGlu…
Latissimus Dorsi Flap Closure
Fluid accumulation in the latissimus dorsi donor site can lead to delayed healing, postponed release from hospital, postoperative seroma and scheduling conflicts associated with return visits for treatment of fluid related complications.
Read more about Latissimus Dorsi Flap Closure with TissuGlu…
The use of TissuGlu as an alternative to drains in patients undergoing mastectomy could provide significant benefit in terms of patient comfort and also possibly reduce time to discharge from hospital.
Read more about No-drain Mastectomy with TissuGlu…
Cohera Medical’s recently completed ‘No Drain’ study confirms that TissuGlu is a clinically superior alternative to closed-suction drains in large flap procedures such as abdominoplasty. In the pivotal clinical trial, when TissuGlu was used, patients required fewer post-operative treatments and resumed normal activities, such as going to work, showering and using the stairs, more quickly.
Currently, most patients who undergo large flap procedures have drains inserted to remove fluid that accumulates under the skin at the surgical site. Drains are often uncomfortable for the patient and can lead to additional complications. TissuGlu forms a strong bond between tissue layers, helping to reduce the space where fluid can accumulate during healing.
Cohera Medical has engaged HealthLink Europe to act as its European Authorized Representative.
*Disclaimer: TissuGlu Surgical Adhesive received European CE Mark in 2011. Currently, TissuGlu Surgical Adhesive is approved for investigational use only in the United States and is not approved for sale or marketing in the U.S. or any other country outside of the EU. No other Cohera Medical product is currently approved for sale in any country.